cabergoline

TERMINATED · PHASE4 · Parkinson Disease

See Detailed Description for termination reason.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.